Skip to Main Content
Table 2—

All-cause and cardiovascular disease mortality by fasting and 2-h postchallenge glucose group for 3,092 adults aged 30 to 74 years in NHANES II

Fasting plasma glucose <7.0 mmol/l
Fasting plasma glucose ≥7.0 mmol/l
2-h plasma glucose (mmol/l)
2-h plasma glucose (mmol/l)
<7.87.8 to 11.1≥11.1<7.87.8 to 11.1≥11.1
Participants 2,321 503 131 23 105 
Person years 31,877 6,533 1,604 125 241 1,230 
Deaths 416 137 47 11 48 
CVD deaths 181 59 23 27 
All-cause       
 Mortality per 1,000 PY 13.1 21.0 29.3 16.0 45.6 39.0 
 RH (95% CI)* 1.0 Reference 1.3 (1.0, 1.6) 1.6 (1.0, 2.6) — — 2.1 (1.4, 3.2) 
 RH (95% CI) 1.0 Reference 1.1 (0.8, 1.6) 1.3 (0.7, 2.5) — — 1.9 (1.1, 3.2) 
CVD death       
 Mortality per 1,000 PY 5.7 9.0 14.3 33.2 22.0 
 RH (95% CI)* 1.0 Reference 1.1 (0.7, 1.5) 1.4 (0.8, 2.5) — — 2.3 (1.4, 3.6) 
 RH (95% CI) 1.0 Reference 1.0 (0.6, 1.6) 1.3 (0.6, 2.8) — — 1.6 (0.8, 3.4) 
Fasting plasma glucose <7.0 mmol/l
Fasting plasma glucose ≥7.0 mmol/l
2-h plasma glucose (mmol/l)
2-h plasma glucose (mmol/l)
<7.87.8 to 11.1≥11.1<7.87.8 to 11.1≥11.1
Participants 2,321 503 131 23 105 
Person years 31,877 6,533 1,604 125 241 1,230 
Deaths 416 137 47 11 48 
CVD deaths 181 59 23 27 
All-cause       
 Mortality per 1,000 PY 13.1 21.0 29.3 16.0 45.6 39.0 
 RH (95% CI)* 1.0 Reference 1.3 (1.0, 1.6) 1.6 (1.0, 2.6) — — 2.1 (1.4, 3.2) 
 RH (95% CI) 1.0 Reference 1.1 (0.8, 1.6) 1.3 (0.7, 2.5) — — 1.9 (1.1, 3.2) 
CVD death       
 Mortality per 1,000 PY 5.7 9.0 14.3 33.2 22.0 
 RH (95% CI)* 1.0 Reference 1.1 (0.7, 1.5) 1.4 (0.8, 2.5) — — 2.3 (1.4, 3.6) 
 RH (95% CI) 1.0 Reference 1.0 (0.6, 1.6) 1.3 (0.6, 2.8) — — 1.6 (0.8, 3.4) 

Data are n unless otherwise stated. — Too few events for stable estimate.

*

RH and 95% CI adjusted for age (continuous) and sex;

adjusted for age (continuous), sex, race (white, nonwhite), education (<high school, ≥high school), smoking (ever, never), physical activity (low, high), BMI (<25, 25≤ to <27, 27≤ to <30, ≥30 kg/m2), systolic blood pressure, and total cholesterol–to–HDL cholesterol ratio (continuous). PY, person years.

Close Modal

or Create an Account

Close Modal
Close Modal